Rocket Pharmaceuticals Stock Market Capitalization
| RCKT Stock | USD 14.39 0.19 1.34% |
Rocket Pharmaceuticals fundamentals help investors to digest information that contributes to Rocket Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Rocket Stock. The fundamental analysis module provides a way to measure Rocket Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rocket Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Market Cap | 2.5 B | 2.6 B |
Rocket | Market Capitalization |
Rocket Pharmaceuticals Company Market Capitalization Analysis
Rocket Pharmaceuticals' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Rocket Pharmaceuticals Market Capitalization | 1.29 B |
Most of Rocket Pharmaceuticals' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rocket Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Rocket Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for Rocket Pharmaceuticals is extremely important. It helps to project a fair market value of Rocket Stock properly, considering its historical fundamentals such as Market Capitalization. Since Rocket Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Rocket Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Rocket Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Rocket Market Capitalization Historical Pattern
Today, most investors in Rocket Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Rocket Pharmaceuticals' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Rocket Pharmaceuticals market capitalization as a starting point in their analysis.
Rocket Pharmaceuticals Market Capitalization |
| Timeline |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Rocket Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of Rocket Pharmaceuticals is about 1.29 B. This is 90.0% lower than that of the Biotechnology sector and 72.7% lower than that of the Health Care industry. The market capitalization for all United States stocks is 93.2% higher than that of the company.
Rocket Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rocket Pharmaceuticals' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rocket Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rocket Pharmaceuticals by comparing valuation metrics of similar companies.Rocket Pharmaceuticals is currently under evaluation in market capitalization category among its peers.
Rocket Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Rocket Pharmaceuticals from analyzing Rocket Pharmaceuticals' financial statements. These drivers represent accounts that assess Rocket Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Rocket Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.1B | 3.0B | 1.4B | 1.3B | 2.5B | 2.6B | |
| Enterprise Value | 977.5M | 2.8B | 1.2B | 1.2B | 2.5B | 2.6B |
Rocket Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Rocket Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Rocket Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Rocket Fundamentals
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | 1.08 B | ||||
| Shares Outstanding | 91.16 M | ||||
| Shares Owned By Insiders | 3.38 % | ||||
| Shares Owned By Institutions | 96.62 % | ||||
| Number Of Shares Shorted | 11.09 M | ||||
| Price To Book | 3.93 X | ||||
| EBITDA | (236.62 M) | ||||
| Net Income | (245.59 M) | ||||
| Cash And Equivalents | 321.37 M | ||||
| Cash Per Share | 4.87 X | ||||
| Total Debt | 25.04 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 13.41 X | ||||
| Book Value Per Share | 3.62 X | ||||
| Cash Flow From Operations | (194.92 M) | ||||
| Short Ratio | 15.00 X | ||||
| Earnings Per Share | (2.73) X | ||||
| Price To Earnings To Growth | 0.03 X | ||||
| Target Price | 46.79 | ||||
| Number Of Employees | 268 | ||||
| Beta | 1.09 | ||||
| Market Capitalization | 1.29 B | ||||
| Total Asset | 566.34 M | ||||
| Retained Earnings | (959.37 M) | ||||
| Working Capital | 329.72 M | ||||
| Net Asset | 566.34 M |
About Rocket Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rocket Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rocket Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rocket Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.